COO (The Cooper) Total Equity: $8,239 Mil (As of Apr. 2026)


COO The Cooper Companies Inc COO
85 GF Score
Price $68.86
GF Value $100.87
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is The Cooper Total Equity?

The Cooper COO +4.04% 85 Total Equity is $8,239 Mil as of Apr. 2026. GuruFocus rates COO with a GF Score™ of 85/100 and a GF Value™ of $100.87 (Significantly Undervalued). The stock has 3 warning signs investors should review.

The Cooper's total equity for the quarter that ended in Apr. 2026 was $8,239 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

The Cooper Total Equity Historical Data

* Premium members only.

The historical data trend for The Cooper's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Cooper Total Equity Chart

The Cooper Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,942.00 7,174.70 7,551.00 8,083.60 8,239.10

The Cooper Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,288.10 8,353.00 8,239.10 8,364.00 8,239.10
COO
85GF Score
The Cooper Companies Inc COO
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Cooper Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

The Cooper's Total Equity for the fiscal year that ended in Oct. 2025 is calculated as

Total Equity=Total Assets(Q: Oct. 2025 )-Total Liabilities(Q: Oct. 2025 )
=12394.8-4155.7
=8,239

The Cooper's Total Equity for the quarter that ended in Apr. 2026 is calculated as

Total Equity=Total Assets(Q: Apr. 2026 )-Total Liabilities(Q: Apr. 2026 )
=12482.3-4243.2
=8,239

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $8,239 Mil mean?
The Cooper (COO) has a Total Equity of $8,239 Mil as of Apr. 2026. The total amount of equity as record on a company's balance sheet. View historical data for The Cooper and its competitors.
Is The Cooper's Total Equity too high?
The Cooper's current Total Equity is $8,239 Mil. Overall, The Cooper has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cooper's Total Equity compare to ALGN and SOLV?
The Cooper's Total Equity of $8,239 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for The Cooper and its competitors. The Cooper's current Total Equity is $8,239 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cooper stock overvalued right now?
Based on GuruFocus' analysis, The Cooper (COO) is currently considered Significantly Undervalued. The stock's GF Value™ is $100.87, compared to a current price of $68.86 — trading 31.7% below its estimated fair value. The current Total Equity is $8,239 Mil. The Cooper's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For The Cooper (COO), the current Total Equity is $8,239 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is The Cooper (COO) Overvalued in 2026?

Based on GuruFocus' analysis, The Cooper stock appears to be undervalued. The current stock price of $68.86 is trading 31.7% below its estimated GF Value™ of $100.87. GuruFocus considers The Cooper to be Significantly Undervalued.

Key valuation signals for COO:

  • Total Equity: $8,239 Mil
  • GF Value™: $100.87 vs. price of $68.86 (31.7% below fair value)
  • GF Score™: 85/100 with 3 warning signs

No single metric tells the full story. See the COO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The Cooper Business Description

Address 6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
85GF Score

Get the complete analysis for COO

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$68.86
Price
$100.87
GF Value